HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeffrey Bacha Selected Research

Dianhydrogalactitol

1/2020Dianhydrogalactitol synergizes with topoisomerase poisons to overcome DNA repair activity in tumor cells.
10/2018Dianhydrogalactitol induces replication-dependent DNA damage in tumor cells preferentially resolved by homologous recombination.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jeffrey Bacha Research Topics

Disease

2Neoplasms (Cancer)
01/2020 - 10/2018
2Glioblastoma (Glioblastoma Multiforme)
01/2020 - 10/2018
1Lung Neoplasms (Lung Cancer)
01/2020
1Prostatic Neoplasms (Prostate Cancer)
01/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2018

Drug/Important Bio-Agent (IBA)

2DNA (Deoxyribonucleic Acid)IBA
01/2020 - 10/2018
2DianhydrogalactitolIBA
01/2020 - 10/2018
1Type II DNA Topoisomerases (Topoisomerase II)IBA
01/2020
1Type I DNA Topoisomerases (Topoisomerase I)IBA
01/2020
1Etoposide (VP 16)FDA LinkGeneric
01/2020
1Irinotecan (Camptosar)FDA LinkGeneric
01/2020
1Temozolomide (Temodar)FDA LinkGeneric
01/2020
1CamptothecinIBA
01/2020
1Docetaxel (Taxotere)FDA Link
01/2020
1PoisonsIBA
01/2020

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2020